Forbes March 19, 2024
Like most pharmaceutical companies, Gilead Sciences Inc. devotes a huge amount of time and money to making sure its products are safe for patients. The U.S. Food and Drug Administration approved its drugs to fight HIV, and these medications have worked remarkably well. It then developed the next generation of HIV medications, and those too have worked well. For that, Gilead is being rewarded with lawsuits—lots of them.
Earlier this year, California’s First District Court of Appeal ruled that lawsuits brought by about 24,000 plaintiffs who say they took Gilead’s initial medications can move forward. They allege Gilead can be liable to them—not because those medications were defective at all—but because they claim Gilead did not develop and market its...
Today's Sponsors
Today's Sponsor